Market Capitalization (Millions $) |
126 |
Shares
Outstanding (Millions) |
51 |
Employees |
2,100 |
Revenues (TTM) (Millions $) |
1,049 |
Net Income (TTM) (Millions $) |
-761 |
Cash Flow (TTM) (Millions $) |
-531 |
Capital Exp. (TTM) (Millions $) |
52 |
Emergent Biosolutions Inc
Emergent BioSolutions Inc. is a publicly traded biotechnology company headquartered in Gaithersburg, Maryland, USA. The company specializes in the development, manufacturing, and commercialization of vaccines and immunotherapies for infectious diseases and biodefense.
Founded in 1998, Emergent BioSolutions has grown to become a leading provider of medical countermeasures to governments, militaries, and private organizations around the world. The company's portfolio of products includes vaccines for anthrax, smallpox, and typhoid fever, as well as treatments for botulism and nerve agents.
Emergent BioSolutions operates a state-of-the-art manufacturing facility in Baltimore, Maryland, which has the capacity to produce millions of vaccine doses per year. The facility is equipped with advanced technologies and processes to ensure the highest levels of quality and safety.
The company has a strong focus on research and development, with dedicated teams working on the discovery and development of new vaccines and therapies. Emergent BioSolutions also partners with leading academic and research institutions to accelerate the development of breakthrough treatments.
In addition to its biodefense work, Emergent BioSolutions is actively involved in developing treatments for infectious diseases such as COVID-19. The company has partnered with other biotech firms and government agencies to develop potential treatments and vaccines for the virus.
Overall, Emergent BioSolutions Inc. is a dynamic and innovative biotech company that is dedicated to improving public health and safety through the development and manufacturing of life-saving vaccines and therapies.
Company Address: 300 Professional Drive Gaithersburg, 20879 MD
Company Phone Number: 631-3200 Stock Exchange / Ticker: NYSE EBS
|